RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Dr Reddy's Laboratories Limited 2023-07-26 Health serious FDA
Health · FDA · Recall #FDA-D-0923-2023

Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's… Recall

Issued July 26, 2023 · Dr Reddy's Laboratories Limited

In July 2023, Dr Reddy's Laboratories Limited recalled the Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.

What you should do

  1. 1 Stop using Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Dr Reddy's Laboratories Limited to arrange your n/a. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (N/A):

Recall details

Brand
Dr Reddy's Laboratories Limited
Category
Health
Recall date
July 26, 2023
Units affected
Not reported
Sold at
Nationwide in the USA
Recall number
FDA-D-0923-2023
Made in
India
Issuing agency
FDA

In context

  • Dr Reddy's Laboratories Limited has 1 recall in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 903rd Health recall we've logged in 2023.
Read the official FDA notice

Related recalls